Karim Saad Temsamani - 01 Oct 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role: Chief Executive Officer, Director
Signature: /s/ Jason Minio, Attorney-in-Fact
Issuer symbol: CDLX
Transactions as of: 01 Oct 2023
Net transactions value: -$408,993
Form type: 4
Filing time: 03 Oct 2023, 18:27:10 UTC
Previous filing: 11 Sep 2023
Next filing: 05 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDLX	Common Stock	Options Exercise		+50,000	+26%		243,768	01 Oct 2023	Direct	F1
transaction	CDLX	Common Stock	Sale	$209,524	-15,463	-6.3%	$13.55	228,305	02 Oct 2023	Direct	F2, F3
transaction	CDLX	Common Stock	Sale	$123,821	-8,299	-3.6%	$14.92	220,006	02 Oct 2023	Direct	F2, F4
transaction	CDLX	Common Stock	Sale	$73,916	-4,708	-2.1%	$15.70	215,298	02 Oct 2023	Direct	F2, F5
transaction	CDLX	Common Stock	Sale	$1,733	-106	-0.05%	$16.35	215,192	02 Oct 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDLX	Restricted Stock Units	Options Exercise	$0	-50,000	-33%	$0.000000	100,000	01 Oct 2023	Common Stock	50,000		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
F2	Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023.
F3	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.21 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
F4	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.27 to $15.265, inclusive.
F5	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.275 to $16.23, inclusive.
F6	This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date.